MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.ejso.2021.01.011

Медицинская библиотека · European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology · 2021

One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison.

Bahadoer Renu R, Bastiaannet Esther, Claassen Yvette H M, van der Mark Marianne, van Eycken Elizabeth, Verbeeck Julie, Guren Marianne G, Kørner Hartwig, Martling Anna, Johansson Robert, van de Velde Cornelis J H, Dekker Jan Willem T

Сравнительное исследованиеСтатьяНаблюдательное исследованиеПеревод пока не подготовлен

Аннотация

BACKGROUND

Mortality in the first postoperative year represents an accurate reflection of the perioperative risk after colorectal cancer surgery. This research compares one-year mortality after surgery divided into three age-categories (18-64, 65-74, ≥75 years), focusing on time trends and comparing treatment strategies.

MATERIAL: Population-based data of all patients diagnosed and treated surgically for stage I-III primary colorectal cancer from 2007 to 2016, were collected from Belgium, the Netherlands, Norway, and Sweden. Stratified for age-category and stage, treatment was evaluated, and 30-day, one-year and one-year excess mortality were calculated for colon and rectal cancer separately. Results were evaluated over two-year time periods.

RESULTS

Data of 206,024 patients were analysed. Postoperative 30-day and one-year mortality reduced significantly over time in all countries and age-categories. Within the oldest age category, in 2015-2016, one-year excess mortality varied from 9% in Belgium to 4% in Sweden for colon cancer and, from 9% in Belgium to 3% in the other countries for rectal cancer. With increasing age, patients were less likely to receive additional therapy besides surgery. In Belgium, colon cancer patients were more often treated with adjuvant chemotherapy (p < 0.001). For neoadjuvant treatment of rectal cancer, patients in Belgium and Norway were mostly treated with chemoradiotherapy. In the Netherlands and Sweden, radiotherapy alone was preferred (p < 0.001).

CONCLUSIONS

Despite improvement over time in all countries and age-categories, substantial variation exists in one-year postoperative mortality. Differences in one-year excess postoperative mortality could be due to differences in treatment strategies, highlighting the consequences of under- and over-treatment on cancer survival.

Для цитирования: Bahadoer Renu R, Bastiaannet Esther, Claassen Yvette H M, van der Mark Marianne, van Eycken Elizabeth, Verbeeck Julie, Guren Marianne G, Kørner Hartwig, Martling Anna, Johansson Robert, van de Velde Cornelis J H, Dekker Jan Willem T. One-year excess mortality and treatment in surgically treated patients with colorectal cancer: A EURECCA European comparison.. European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2021. DOI: 10.1016/j.ejso.2021.01.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.